An interventional study of No Restoration Control Group and Resin-Modified Glass Ionomer Cement Restoration in Gingival Recession and Non-Carious Cervical Lesions (NCCLs), sponsored by Zeliha Başak Çakır Erdil. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Zeliha Başak Çakır Erdil · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 69 studies in Gingival Recession with a site in Turkey — 13 open to participants now, 14 under way, none of them phase 3. Gingival Recession · Turkey.
Among the 69 studies in Gingival Recession with a site in Turkey, this one is the 15th largest by enrollment of the 56 interventional ones that give a count, is one of 6 that started in 2026, is one of 52 with no phase, and was the 63rd registered.
430 studies on the registry are indexed under Gingival Recession; 105 are open to participants now.
Browse Gingival Recession studies →13 of the 69 studies in Gingival Recession with a site in Turkey are open now. Recruiting first, the newest first:
Altinbas University · Sites in Turkey
Ages 18+
Trakya University · Sites in Turkey
Ages 18–65
Kahramanmaras Sutcu Imam University · Sites in Turkey
Ages 18+ · Healthy volunteers
Marmara University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Inonu University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 63 Gingival Recession studies recruiting now, 30 (48%) set no upper age limit and 30 (48%) stop at 75 or younger; 1 takes children under 18; 36 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
69 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 2 · Phase 3 1
First in 2010; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 47 is above the median of 30 across 394 interventional studies indexed under Gingival Recession.
Median enrollment 37 across the 56 interventional studies, 80 across the 13 observational. Of the 53 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 69 has an industry lead sponsor. The 10 most frequent:
Zeliha Başak Çakır Erdil is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Zeliha Başak Çakır Erdil has 1 study filed under Gingival Recession — fewer than ten, so there is no comparison to draw.
4 of the studies in Gingival Recession with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07804888Saglik Bilimleri UniversitesiEvaluation of the Effects of Injectable Platelet-Rich Fibrin and Hyaluronic Acid Treatments, Administered in Addition to Free Gingival Graft Therapy, on Clinical Healing. | 2027-01 |
| NCT07777185Ankara UniversityEvaluation of the Effect of Smoking on Palatal Donor Site Tissue Profile in the Success of Connective Tissue Grafts | 2027-02-20 |
| NCT07349056Trakya UniversityEarly Effects of Orthognathic Surgery on Periodontal Phenotype: A 6-Month Prospective Clinical and Radiographic Evaluation | 2027-02-23 |
| NCT07751211Altinbas UniversityEffects of Low-Level Laser Therapy and Hyaluronic Acid After Free Gingival Graft | 2027-03-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 69 studies in Gingival Recession with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective observational study evaluated whether the presence and type of cervical restoration were associated with the outcomes of root coverage surgery in patients with gingival recession and non-carious cervical lesions.
The study included 47 patients and 104 teeth divided into three groups: teeth without restoration, teeth restored with composite resin, and teeth restored with resin-modified glass ionomer cement. Restorative treatment decisions were made independently by the treating clinicians according to clinical needs, without random assignment.
All teeth underwent root coverage surgery combined with a subepithelial connective tissue graft. Clinical measurements were recorded before surgery and three months after surgery to compare gingival recession and root coverage outcomes among the groups.
Gingival recession associated with non-carious cervical lesions (NCCLs) presents a clinical challenge because cervical hard-tissue defects and existing restorations may influence periodontal soft-tissue healing and root coverage outcomes.
This prospective, non-randomized observational study was conducted at the Faculty of Dentistry, Adıyaman University, Türkiye. The study included 47 patients with 104 teeth presenting with Cairo RT1 gingival recession associated with NCCLs.
The teeth were classified into three groups according to their restorative status: an unrestored group (43 teeth), a composite resin group (35 teeth), and a resin-modified glass ionomer cement group (26 teeth). Teeth with cervical lesion depths of 1.5 mm or less were managed without restoration, whereas teeth with lesion depths of 2 mm or greater received restorative treatment. The decision regarding restorative treatment and material selection was made by the treating clinicians based on clinical indications and was not determined by randomization or research-related treatment assignment.
All teeth underwent periodontal root coverage surgery combined with a subepithelial connective tissue graft. The surgical approach, including coronally advanced flap, tunnel, or modified tunnel techniques, was selected according to clinical indications.
Clinical periodontal measurements were obtained at baseline and three months after surgery. Outcomes included mid-buccal gingival recession depth and percentage of root coverage. Comparisons were performed among the three restorative groups to evaluate the association between restorative status, restorative material, and clinical root coverage outcomes.
Because patients could contribute more than one tooth, the analysis accounted for clustering of teeth within patients where applicable. The study evaluated clinical outcomes under the treatment decisions made in routine practice rather than testing randomly assigned restorative interventions.
The criteria were revised on the registry on Nov 12, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Teeth with non-carious cervical lesions measuring 1.5 mm or less were managed without restorative treatment. Root coverage surgery was performed using a coronally advanced flap, tunnel, or modified tunnel technique according to clinical indications, combined with a subepithelial connective tissue graft. A total of 43 teeth from 23 patients were included in this group. Treatment allocation was not randomized.
Procedure: No Restoration Control Group
Teeth with non-carious cervical lesions measuring 2 mm or deeper were restored with resin-modified glass ionomer cement (Fuji II LC, GC Corporation, Tokyo, Japan) before periodontal surgery. Restorative material selection was based on clinical judgment rather than random allocation. Root coverage surgery was performed using a coronally advanced flap, tunnel, or modified tunnel technique combined with a subepithelial connective tissue graft. This group included 26 teeth from 14 patients.
Device: Resin-Modified Glass Ionomer Cement Restoration
Teeth with non-carious cervical lesions measuring 2 mm or deeper were restored with composite resin (Filtek Z250, 3M ESPE, St. Paul, MN, USA) before periodontal surgery. The restorative material was selected by the treating restorative clinician according to clinical indications without random allocation. Root coverage surgery was performed using a coronally advanced flap, tunnel, or modified tunnel technique combined with a subepithelial connective tissue graft. This group included 35 teeth from 16 patients.
Device: Resin Composite Group
No restorative material was applied to the non-carious cervical lesion before periodontal surgery. Root coverage surgery was performed using a coronally advanced flap, tunnel, or modified tunnel technique according to clinical indications. A subepithelial connective tissue graft harvested from the palate was used in all cases.
Non-carious cervical lesions were restored with light-cured resin-modified glass ionomer cement (Fuji II LC, GC Corporation, Tokyo, Japan). Restorations were completed before periodontal surgery, which was performed using a clinically selected root coverage technique combined with a subepithelial connective tissue graft.
Non-carious cervical lesions were restored with light-cured composite resin (Filtek Z250, 3M ESPE, St. Paul, MN, USA). Restorations were completed before periodontal surgery, which was performed using a clinically selected root coverage technique combined with a subepithelial connective tissue graft.
Mid-Buccal Gingival Recession Depth at Three Months
Mid-buccal gingival recession depth was measured in millimeters from the cementoenamel junction or its estimated reference position to the gingival margin. Measurements obtained at baseline and three months after root coverage surgery were compared among the unrestored, composite resin, and resin-modified glass ionomer cement groups.
Time frame: Baseline and 3 months after surgery
Percentage of Root Coverage at Three Months
Percentage of root coverage was calculated from the change in gingival recession depth between baseline and three months after surgery. Root coverage outcomes were compared among unrestored, composite resin-restored, and resin-modified glass ionomer cement-restored teeth.
Time frame: Baseline and 3 months after surgery
Plan to share: No — Individual participant data will not be made publicly available due to participant confidentiality and data protection considerations. Aggregate study findings will be reported in the published manuscript.
No publications or documents are linked to this record.
Ran from Jan 2026 to primary completion in Aug 2026, 6 months.
Of 237 non-industry interventional studies with no phase under Gingival Recession, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 6 months is below that.
Counting every sponsor, half of 239 studies reached it within 19 months; a quarter within 11 and three quarters within 30.
Start moved once since we started tracking on Sep 25, 2026: Nov 2025 → Jan 2026, on Nov 12, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zeliha Başak Çakır Erdil